Abstract

BackgroundResearch on the sexual networks of transwomen is central to explaining higher HIV risk for this population. This study examined HIV risk behaviors and sexual mixing patterns of transwomen by demographic and HIV-related risk behaviors.MethodsData were obtained from a 2010 study of HIV risk for transwomen in San Francisco. Assortativity by race, partner type, HIV serostatus, and IDU across sexual networks was calculated using Newman’s assortativity coefficient (NC). Multivariable generalized estimating equations (GEE) logistic regression models were used to evaluate associations between unprotected anal intercourse with race and HIV serostatus, partner-IDU status and relationship type discordance while adjusting for the HIV status of transwomen.ResultsThere were 235 sexually active transwomen in this study, of whom 104 (44.3%) were HIV-positive and 73 (31.1%) had a history of injection drug use. Within the 575 partnerships, African American/black and Latina transwomen were the most racially assortative (NC 0.40, 95% CI 0.34-0.45, and NC 0.43, 95% CI 0.38-0.49, respectively). In partnerships where the partner’s HIV status was known (n = 309, 53.7%), most transwomen were in sexual partnerships with people of their same known serostatus (71.8%, n = 222). In multivariable analyses, unprotected anal intercourse was significantly associated with primary partners, having a sexual partner who was an injection drug user, and sexual partner seroconcordance.ConclusionsPublic health efforts to reduce transwomen’s HIV risk would likely benefit from prioritizing prevention efforts to risk reduction within IDU-discordant and primary partnerships, determining risks attributable to sexual network characteristics, and actively addressing injection drug use among transwomen.

Highlights

  • Research on the sexual networks of transwomen is central to explaining higher HIV risk for this population

  • Multivariable analysis of engagement in sexual risk behavior In the primary outcome multivariable analysis, we evaluated the associations between UAI with sexual partners and discordance in race and HIV serostatus, as well as partner-IDU status and relationship type, while adjusting for the HIV status of transwomen

  • In the final analysis we found that UAI was significantly associated with having a sexual partner who was an injection drug user, primary partner, and/or HIV seroconcordant

Read more

Summary

Introduction

Research on the sexual networks of transwomen is central to explaining higher HIV risk for this population. A systematic review of HIV research in the US found that transgender women (transwomen) engage in high rates of unprotected receptive anal intercourse, which may explain elevated rates of HIV [1]. A recent population-based study of transwomen found that testing positive for HIV was significantly related to methamphetamine use, methamphetamine use before or during anal intercourse, and at least weekly methamphetamine use [9]. Risk related to injection hormones is mixed as one study found that a combination measure of injection drug and hormone use to be related to self-reported HIV infection, while another recent study of injection of fillers (i.e. illicit substances used to feminize transwomen’s appearance) found no association with an HIV positive test [8,13]. Data are missing on HIV risk related to sex with injection drug users among transwomen, it is difficult to discern whether IDUrelated risk among transwomen is due to injection drug use practices of transwomen, their sexual partners who are IDU, or both

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call